Replies to post #1726 on TetraLogic Pharmaceuticals Corp (TLOG)

[zoomlik]

Remember if efficacy data is promising for the selected dose of 22mg, then birinapant has potential to find a room in oncology spaces as a partner for keytruda

This makes senior debt of say $50M
quite manageble and tlog shareholder could be valuable option on future sales of birinapant


(my $50M assumes debt and intersex of $60M in 2024 minus $10M for milestone for enrolling first patient in a P3 and no milestone from HDAC compound )